Panostaja Oyj
Panostaja Oyj Managers' Transactions
Panostaja Oyj Stock Exchange Bulletin, Managers´ Transactions March 17, 2021 at 16:45 pm.
| Person subject to the notification requirement | ||
| Name: | Ala-Mello, Jukka | |
| Position: | Member of the Board/Deputy member | |
| Initial Notification | ||
| Reference number: | 743700ZGH7GD27UOQO12_20210317122248_24 | |
| Issuer | ||
| Name: | Panostaja Oyj | |
| LEI: | 743700ZGH7GD27UOQO12 | |
| Transaction details | ||
| Transaction date: | 2021-03-17 | |
| Venue: | NASDAQ HELSINKI LTD (XHEL) | |
| Nature of the transaction: | Receipt of a Share-Based Incentive or Remuneration | |
| Instrument: | Share | |
| ISIN: | FI0009800379 | |
| Volume: | 5405 | |
| Unit price: | 0,00000 Euro | |
| Aggregated transactions | ||
| Volume: | 5405 | |
| Volume weighted average price: | 0.00000 Euro | |
PANOSTAJA OYJ
For further information, contact CEO Tapio Tommila: tel. +358 (0)40-527 6311
www.panostaja.fi/en/
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Global Allergy and Airways Patient Platform26.10.2025 20:17:14 CET | Press release
New Global Coalition Launches to Address the Hidden Threat of RSV in Adults
ARETI International Group26.10.2025 18:41:15 CET | Press release
ARETI International Group, Headed by Igor Makarov, Partners with INEX CLUB to Support the Mayflower Gran Prix Cyprus 2025
Novartis Pharma AG26.10.2025 18:00:00 CET | Press release
Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline
mediCAD Hectec GmbH26.10.2025 12:45:00 CET | Press release
mediCAD® 8 Revolutionizes Orthopedic and Trauma Planning with Intelligent AI Integration
Novartis Pharma AG25.10.2025 17:00:00 CEST | Press release
Novartis showcases significant immunology advancements in ACR congress with new data in complex autoimmune diseases
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom